Jupiter Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Jupiter Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,500	Closed	-$455K	–	90
2020 Q2	$455K	Hold	1,500	–	–	0.23%	52
2020 Q1	$382K	Hold	1,500	–	–	0.22%	50
2019 Q4	$345K	Hold	1,500	–	–	0.17%	68
2019 Q3	$254K	Hold	1,500	–	–	0.14%	70
2019 Q2	$266K	Buy	+1,500	New	+$262K	0.13%	71

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jupiter Wealth Management's VRTX Position: Q3 2020 in Review

Jupiter Wealth Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2020, closing a stake of 1,500 shares — an estimated $455K sold.

Jupiter Wealth Management first reported a position in VRTX in Q2 2019 and held it in 5 quarters. The position peaked at $455K in Q2 2020. 951 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

Jupiter Wealth Management reported no remaining Vertex Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Jupiter Wealth Management sold 1,500 Vertex Pharmaceuticals shares in Q3 2020, an estimated $455K.
Jupiter Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2019 and held it in 5 quarters.
Jupiter Wealth Management's Vertex Pharmaceuticals position peaked at $455K in Q2 2020.
951 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on Jupiter Wealth Management's 13F filing for Q3 2020, filed 19 Nov 2020.